Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
McCormick & Co. Inc. Stock Slides 4.9%, Underperforms Peers

McCormick & Co. Inc. Stock Slides 4.9%, Underperforms Peers

Dow JonesDow Jones2026/10/01 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of McCormick & Co. Inc. slipped 4.9% to $44.14 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.2% to 7,666.45 and the Dow Jones Industrial Average remaining mostly unchanged at 50,926.56.

This was the stock's third consecutive day of losses.

McCormick & Co. Inc. closed 39.0% below its 52-week high of $72.41, which the company reached on February 13th.

The stock underperformed when compared to some of its peers, as Kraft Heinz Co. fell 1.1% to $22.46, Archer Daniels Midland Co. rose 0.2% to $79.52, and Conagra Brands Inc. fell 1.79% to $13.20.

Trading volume totaled 8.9 million, compared to the 50-day average of 3.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 01, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The battle for customer loyalty heats up ahead of the holiday season! Walmart (WMT.US) launches a $120 membership package, going head-to-head with Amazon Prime and Costco.

Walmart launched a joint membership package for Walmart+ and Sam’s Club Plus this week, directly competing with Amazon Prime and Costco.

智通财经•2026/10/26 01:51
The battle for customer loyalty heats up ahead of the holiday season! Walmart (WMT.US) launches a $120 membership package, going head-to-head with Amazon Prime and Costco.

Data: ETH falls below 2,300 USD

Chaincatcher•2026/10/26 01:51

Survival period doubled! AstraZeneca's new stomach cancer drug Sone-ve aims for $5 billion in annual sales, ADC takes another step towards replacing chemotherapy

AstraZeneca's gastric cancer ADC doubles patient survival, extending life by five more months, aiming for annual sales of $5 billion; the company is racing with Takeda and Astellas to target Claudin 18.2.

智通财经•2026/10/26 01:36

16 trillion Korean won "big dividend"! SK hynix (SKHY.US) plans to distribute 80% of Kioxia stake earnings generously to shareholders

According to reports, SK Hynix plans to return about 80% of the proceeds from reducing its stake in Japan's Kioxia Holdings to shareholders by distributing a special dividend of approximately 16 trillion won (about $12 billion).

智通财经•2026/10/26 01:22